Review



vce-003.2  (Emerald Health Pharmaceuticals)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Emerald Health Pharmaceuticals vce-003.2
    Vce 003.2, supplied by Emerald Health Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vce-003%2E2/vce+003+2/pm37759872-53-13-16
    Average 90 stars, based on 1 article reviews
    vce-003.2 - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Development of An Oral Treatment with the PPAR-γ-Acting Cannabinoid VCE-003.2 Against the Inflammation-Driven Neuronal Deterioration in Experimental Parkinson’s Disease
    Article Snippet: Acknowledgments: Authors are indebted to Yolanda García-Movellán for administrative support and to Emerald Health Pharmaceuticals for providing VCE-003.2 for oral administration.

    Article Title: The Cannabigerol Derivative VCE-003.2 Exerts Therapeutic Effects in 6-Hydroxydopamine-Lesioned Mice: Comparison with The Classic Dopaminergic Replacement Therapy.
    Article Snippet: After the application of 6-OHDA, animals were treated with the following compounds: (i) VCE-003.2 (provided by Emerald Health Pharmaceuticals, San Diego, CA, USA) given orally at a dose of 20 mg/kg according to previous studies [29], initiating the treatment at 24 h after the lesion and daily repeating during 14 days; (ii) L-DOPA (Sigma-Aldrich Chem., Madrid, Spain) and benserazide (Sigma-Aldrich Chem., Madrid, Spain), given i.p. at the dose of 2 mg/kg in both cases according to previous studies [33], initiating the treatment 7 days after the lesion and daily repeating during 7 additional days (as indicated before, the use of a shorter treatment was necessary to diminish the occurrence of dyskinesia [33]); or (iii) the vehicle for VCE-003.2 (sesame oil) given orally during 14 days (50% of mice in this group) and the vehicle for L-DOPA/benserazide (0.9% saline) given i.p. during 7 days (remaining 50% of animals).

    Article Title: The Cannabigerol Derivative VCE-003.2 Exerts Therapeutic Effects in 6-Hydroxydopamine-Lesioned Mice: Comparison with The Classic Dopaminergic Replacement Therapy
    Article Snippet: After the application of 6-OHDA, animals were treated with the following compounds: (i) VCE-003.2 (provided by Emerald Health Pharmaceuticals, San Diego, CA, USA) given orally at a dose of 20 mg/kg according to previous studies [ ], initiating the treatment at 24 h after the lesion and daily repeating during 14 days; (ii) L-DOPA (Sigma-Aldrich Chem., Madrid, Spain) and benserazide (Sigma-Aldrich Chem., Madrid, Spain), given i.p. at the dose of 2 mg/kg in both cases according to previous studies [ ], initiating the treatment 7 days after the lesion and daily repeating during 7 additional days (as indicated before, the use of a shorter treatment was necessary to diminish the occurrence of dyskinesia [ ]); or (iii) the vehicle for VCE-003.2 (sesame oil) given orally during 14 days (50% of mice in this group) and the vehicle for L-DOPA/benserazide (0.9% saline) given i.p. during 7 days (remaining 50% of animals).



    Similar Products

    pharmacokinetic for oral vce-003.2  (Charles River Laboratories)
    90
    Charles River Laboratories pharmacokinetic for oral vce-003.2
    Pharmacokinetic For Oral Vce 003.2, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vce-003%2E2/pharmacokinetic+for+oral+vce+003+2/pm39487447-77-3-29
    Average 90 stars, based on 1 article reviews
    pharmacokinetic for oral vce-003.2 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    pharmacokinetic for oral vce-003.2  (Eurofins)
    90
    Eurofins pharmacokinetic for oral vce-003.2
    Pharmacokinetic For Oral Vce 003.2, supplied by Eurofins, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vce-003%2E2/pharmacokinetic+for+oral+vce+003+2/pm39487447-77-3-34
    Average 90 stars, based on 1 article reviews
    pharmacokinetic for oral vce-003.2 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    vce-003.2  (Emerald Health Pharmaceuticals)
    90
    Emerald Health Pharmaceuticals vce-003.2
    Vce 003.2, supplied by Emerald Health Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vce-003%2E2/vce+003+2/pm37759872-53-13-16
    Average 90 stars, based on 1 article reviews
    vce-003.2 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results